Vyome Holdings, Inc. ("Vyome") , a clinical-stage biopharmaceutical company focused on developing therapies for serious immuno-inflammatory and rare conditions, today announced that it has filed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results